News
Recent news
Subscribe to Southwest Michigan Innovation Center's RSS feed.
Orphan drug status approved for NephRx product
Posted by NephRx Corporation on August 26, 2010:
By Kathy Jennings for Southwest Michigan's Second Wave
NephRx, a Kalamazoo-based biotech startup that is developing a product for use in renal disease and inflammatory gastro-intestinal disorders, has gotten good news.
The company's lead product, known as NX001, has been awarded orphan drug status by the U ... Read more
Michigan awards $530,000 in loans to five companies to hire ex-Pfizer employees
Posted by Kalamazoo Gazette on August 25, 2010:
By Alex Nixon
A Kalamazoo company is one of five Michigan firms that received funding from the state to hire ex-Pfizer Inc. workers, according to a press release today from the Michigan Economic Development Corp.
Single Source Procurement LLC, in Kalamazoo, was founded by an ex-Pfizer employee in 2003 and provides specialized purchasing and sourcing services to clients of the Southwest Michigan Innovation Center, according to the state ... Read more
Kalamazoo drug-discovery firm NanoVir receives $3 million grant
Posted by Kalamazoo Gazette on August 10, 2010:
KALAMAZOO — The National Institutes of Health is providing Kalamazoo-based NanoVir another $3 million to fund research into new drugs candidates to fight the viruses that cause cervical cancer.
The three-year grant announced Tuesday, complements a $1 ... Read more
Kalamazoo-based biopharmaceutical company secures funding from West Michigan investors, MEDC
Posted by Business Review Western Michigan on July 26, 2010:
ProNAi Therapeutics Inc., a privately-held biopharmaceutical company based in Kalamazoo, has secured financing to advance Phase I clinical studies of a cancer drug.
ProNAi raised the capital from a group of Michigan investors, including Kalamazoo-based Apjohn Ventures, West Michigan angel investing group Grand Angels, and the Michigan Economic Development Corp ... Read more
Firm works on diabetic drugs without side effects
Posted by Detroit Free Press on July 25, 2010:
By Patricia Anstett
Free Press Medical Writer
With the fate of a top-selling diabetes drug mired in controversy, Kalamazoo scientists are working to develop the next generation of medicines that improve diabetic care without serious side effects.
Metabolic Solutions Development is a start-up Michigan company with two drugs in its pipeline to improve blood glucose and insulin measurements without causing the weight gain, fluid retention and heart problems associated with Avandia ... Read more
